Browse
Submit Data
Databases
API
Help

Dataset Information

21 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acrylato[tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate-dimethyl-formamide-methanol (1/1/1.5)?at 153?(2) K.

ABSTRACT: In the title complex, [Zn(C(3)H(3)O(2))(C(27)H(27)N(7))](ClO(4))·C(3)H(7)NO·1.5CH(4)O, the Zn(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.84 and 0.16. In addition, a methanol solvent mol-ecule is disordered over two sites with equal occupancies. In the crystal structure, the full-occupancy methanol is linked to a dimethyl-formamide mol-ecule by an inter-molecular O-H?O hydrogen bond.

SUBMITTER: Tian Y

PROVIDER: S-EPMC2960207 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Acrylato[tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate-dimethyl-formamide-methanol (1/1/1.5) at 153 (2) K.

Tian Yongqiang Y Wu Huilu H Yun Ruirui R Yuan Jingkun J Ding Jian J

Acta crystallographica. Section E, Structure reports online 20080109 Pt 2

In the title complex, [Zn(C(3)H(3)O(2))(C(27)H(27)N(7))](ClO(4))·C(3)H(7)NO·1.5CH(4)O, the Zn(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.84 and 0.16. In addition, a methanol solvent mol-ecule is disordered ...[more]

PMID: 21201287

Similar Datasets

Acrylato[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]cobalt(II) perchlorate-dimethyl-formamide-methanol (2/2/3).

Project description:In the title complex, [Co(C(3)H(3)O(2))(C(27)H(27)N(7))]ClO(4)·C(3)H(7)NO·1.5CH(4)O, the Co(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.90 and 0.10. In addition, the solvent hemimethanol mol-ecule is disordered over two positions with equal occupancies. The crystal structure is stabilized by weak intermolecular O-H⋯O hydrogen bonds.

| S-EPMC2959638 | biostudies-literature

Salicylato[tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate dimethyl-formamide sesquisolvate.

Project description:In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), with approximate mol-ecular C(3) symmetry. One dimethyl-formamide mol-ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl-formamide mol-ecule is disordered about a twofold rotation axis.

| S-EPMC2915077 | biostudies-literature

(Dimethyl-formamide)(2-methyl-propen-oato)[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]-manganese(II) perchlorate dimethyl-formamide solvate.

Project description:In the title complex, [Mn(C(4)H(5)O(2))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is seven-coordinated in a distorted monocapped trigonal-prismatic geometry formed by a tetra-dentate tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine mol-ecule, a bidentate 2-methacrylate anion and a dimethyl-formamide mol-ecule. The methyl groups of the coordinated dimethyl-formamide mol-ecule and the perchlorate anions are disordered over two positions with occupancy factors of 0.640 (8) and 0.360 (8).

| S-EPMC2983334 | biostudies-literature

(Salicylato)[tris-(1-methyl-1H-benz-imidazol-2-ylmeth-yl)amine]copper(II) perchlorate dimethyl-formamide disolvate.

Project description:In the title complex, [Cu(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·2C(3)H(7)NO, the Cu(II) ion is five-coordinated by four N atoms from the tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine ligand and an O atom of the monodentate salicylate ligand. The N(4)O donor set defines a coordination geometry inter-mediate between square-pyramidal and trigonal-bipyramidal. The crystal structure is stabilized by O-H⋯O inter-actions. The atoms of the aromatic ring of the salicylate ligand are disordered over two sites of equal occupancy. In addition, one of the dimethyl-formamide solvent mol-ecules is partially disordered over two positions, of approximately equal occupancy.

| S-EPMC2914911 | biostudies-literature

(2-Hydroxy-benzoato-κO)[tris-(1-methyl-benzimidazol-2-ylmethyl-κN)amine-κN]cobalt(II) perchlorate dimethyl-formamide sesquisolvate.

Project description:In the title complex, [Co(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Co(II) ion is five-coordinated by four N atoms from a tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The perchlorate ion is disordered over two sites with equal occupancy. One dimethyl-formamide solvent mol-ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl-formamide mol-ecule is disordered about a twofold rotation axis. There is an intra-molecular O-H⋯O hydrogen bond in the cation.

| S-EPMC2959500 | biostudies-literature

Tris(1H-benzimidazol-3-ium-2-ylmeth-yl)amine tris-(2,4,6-trinitro-phenolate) acetonitrile disolvate.

Project description:In the cation of the title salt, C(24)H(24)N(7) (3+)·3C(6)H(2)N(3)O(7) (-)·2C(2)H(3)N, the three benzimidazolium ring systems are oriented to each other at dihedral angles of 10.42 (7), 23.98 (7) and 22.17 (7)°. In the crystal, the cation links to the adjacent picrate anions via N-H⋯O hydrogen bonds; one of independent acetonitrile solvent mol-ecules is also linked to the cation via an N-H⋯N hydrogen bond.

| S-EPMC3379477 | biostudies-literature

(Dimethyl-formamide-κO)(2-hy-droxy-benzoato-κO,O)[tris-(1-methyl-1H-benzimidazol-2-ylmethyl-κN)amine-κN]manganese(II) perchlorate dimethyl-formamide monosolvate.

Project description:In the title complex, [Mn(C(7)H(5)O(3))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand coordinates in a tetra-dentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethyl-formamide ligand. The hy-droxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites with occupancies of 0.581 (8) and 0.419 (8). Both disorder components of the hy-droxy group form intra-molecular O-H⋯O hydrogen bonds.

| S-EPMC2983134 | biostudies-literature

Dichlorido[tris-(benzimidazol-2-ylmeth-yl)amine]-indium(III) chloride ethanol solvate dihydrate.

Project description:In the title complex, [InCl(2)(C(24)H(21)N(7))]Cl·C(2)H(5)OH·2H(2)O, the In(III) ion is coordinated by four N atoms from the tris-(benz-imidazol-2-ylmeth-yl)amine (NTB) ligand and two Cl atoms in a distorted octa-hedral environment. In the crystal structure, inter-molecular N-H?O, O-H?O, O-H?Cl and weak C-H?Cl hydrogen bonds connect the cations, anions and solvent mol-ecules into a three-dimensional network. The ethanol solvent mol-ecule is disordered over two sites with refined occupancies of 0.54?(2) and 0.46?(2).

| S-EPMC3007265 | biostudies-literature

Bis[bis-(1H-benzimidazol-2-ylmeth-yl)amine]copper(II) dichloride methanol disolvate dihydrate.

Project description:In the title compound, [Cu(C(16)H(14)N(5))(2)]Cl(2)·2CH(4)O·2H(2)O, the cationic metal complex resides on a crystallographic centre of inversion, with the Cu(2+) bonded to two bis-(1H-benzimidazol-2-ylmeth-yl)amines (IDB). The coordination geometry of the Cu(2+) ion is distorted octa-hedral with an N(6) ligand set. A three-dimensional framework structure is formed by means of hydrogen bonds and π-π inter-actions formed between imidazole and phenyl rings, and between phenyl and phenyl rings, with centroid-to-centroid distances of 3.690 (2)-3.977 (2) Å and interplanar spacings of 3.445 (2)-3.502 (2) Å.

| S-EPMC2915122 | biostudies-literature

[N,N,N',N'-Tetra-kis(benzimidazol-2-ylmeth-yl)cyclo-hexane-1,2-trans-diamine]-iron(II) bis-(perchlorate) methanol solvate.

Project description:In the title compound, [Fe(C(38)H(38)N(10))](ClO(4))(2)·CH(3)OH, the Fe(II) atom has a distorted octa-hedral coordination environment with four benzimidazol N atoms and two amino N atoms from an N,N,N',N'-tetra-kis-(benzimidazol-2-ylmeth-yl)cyclo-hexane-1,2-trans-diamine ligand. The uncoordinated solvent methanol mol-ecule is hydrogen bonded to an O atom of a perchlorate anion. One of the perchlorate anions is disordered over two sets of sites with occupancy factors of 0.539?(14) and 0.461?(14). N-H?O and C-H?O hydrogen bonds, as well as ?-? stacking inter-actions between the imidazol rings and between the imidazol and benzene rings [centroid-centroid distances = 3.714?(2) and 3.705?(2)?Å] give rise to a three-dimensional network.

| S-EPMC3089232 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data